Tiziana Life Sciences PLC (TLSA: NASDAQ) Clinical

Research Note Clinical Results for Second SPMS Patient NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences PLC (NASDAQ: TLSA)...

Related Keywords

Hana Malik , Intranasalforalumab Firstspmspatient , Tiziana Life Sciences , Tiziana Life Sciences Ltd , Access Program , Business Development , Expanded Access , Individual Patient Expanded Access , Individual Access , Standardized Uptake Value Ratio , Walk Test , Hole Peg Test , Symbol Digit Modality Test , Month Reduction , Tiziana Pipeline , Investor Relations Manager , Nasdaq Tlsa , Tiziana Life Sciences Plc ,